Sudarshan Pharma Industries Ltd — Updates, 14-08-2025: Company Update

Sudarshan Pharma Industries' Board has approved a strategic acquisition of capital assets for Rs. 25.50 Crore. The company is acquiring land, building, and plant & machinery totaling 1,563.15 square meters from Srigen Lifesciences Private Limited in Medchal, Telangana. This significant investment, paid in cash, is set to substantially enlarge Sudarshan Pharma's production capabilities for pharmaceutical and chemical products, including API key starting materials. The acquired facility boasts an 80 Kilolitres reactor capacity, enhancing commercial manufacturing. This move is a direct step towards boosting future output and operational efficiency for the company.